S21L (p.Ser21Leu) variant of TRAF3IP2 (E3 ubiquitin ligase TRAF3IP2)
S21L (p.Ser21Leu) in TRAF3IP2 (E3 ubiquitin ligase TRAF3IP2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.39 / 1. The record also includes population frequency data and structural context.
S21L (p.Ser21Leu) variant details
- p.Ser21Leu
- rs758695030
- NCI-TCGA Cosmic COSV6067
- cosmic curated COSV60674
- ExAC rs758695030
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.39
- AlphaMissense 0.18
- MetaLR 0.17
- MetaSVM -0.82
- PolyPhen-2 1.00
- SIFT 0.00
- EVE 0.48
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available